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Abstract
Background: Human height is considered highly heritable and correlated with certain disorders, such as type 2 
diabetes and cancer. Despite environmental influences, genetic factors are known to play an important role in stature 
determination. A number of genetic determinants of adult height have already been established through genome 
wide association studies.
Methods: To examine 51 single nucleotide polymorphisms (SNPs) corresponding to the 46 previously reported 
genomic loci for height in 8,184 European American children with height measurements. We leveraged genotyping 
data from our ongoing GWA study of height variation in children in order to query the 51 SNPs in this pediatric cohort.
Results: Sixteen of these SNPs yielded at least nominally significant association to height, representing fifteen different 
loci including EFEMP1-PNPT1, GPR126, C6orf173, SPAG17, Histone class 1, HLA class III and GDF5-UQCC. Other loci 
revealed no evidence for association, including HMGA1 and HMGA2. For the 16 associated variants, the genotype score 
explained 1.64% of the total variation for height z-score.
Conclusion: Among 46 loci that have been reported to associate with adult height to date, at least 15 also contribute 
to the determination of height in childhood.
Background
H e i g h t  h a s  b e e n  c o r r e l a t e d  w i t h  v a r i o u s  d i s o r d e r s ,
including the observations that taller people are at a
higher risk of developing cancer and shorter people are
more likely to present with type 2 diabetes [1-3]. Deter-
mination of height in humans has long been considered
to be largely influenced by genetic factors; indeed, twin
and family studies have suggested that as much as 90% of
variation in human height is genetically determined[4-8].
For many years, studies have attempted to identify
genetic factors influencing human height in order to pro-
vide insights into human growth and development. Prior
to 2007, genome-wide linkage and candidate-gene associ-
ation studies had limited success in this regard; however,
with the recent emergence of genome wide association
(GWA) studies, tens of common genetics variants influ-
encing height have now been uncovered, primarily in
adults[9-14].
Weedon et al published the first GWA study of height
using the Affymetrix GeneChip Human Mapping 500 K
platform on nearly 5,000 individuals of self-reported
European ancestry[9]. As a consequence, they observed
association to common variation in the mobility group-
A2 (HMGA2) oncogene. Follow-up analyses in approxi-
mately 19,000 more individuals (both adults and chil-
dren) revealed strong replication of this observation. A
subsequent GWA study uncovered another height locus,
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GDF5-UQCC,  u s i n g  d a t a  f r o m  t h e  F U S I O N  a n d  S a r -
diNIA cohorts[10].
These initial discoveries were followed by four meta-
analyses with larger sample sizes, which collectively
revealed 44 additional height loci [11-14]. However, some
lack of overlap between the results of these GWA studies
has been observed, which may be partly explained by the
different statistical powers of the studies[15].
Although the causal variants at these loci have still to be
elucidated, it has been shown that many of the implicated
genes are involved in pathways influencing bone and car-
tilage development, including skeletal development sig-
naling (PTCH1, HHIP, BMPs, GDF5), the extracellular
matrix (ACAN, FBLN5, EFEMP1, ADAMTS17,
ADAMTSL3), chromatin structure and regulation
(DOT1L, SCMH1, HMGA2) and cell cycle regulation and
mitosis (CDK6, ANAPC13, NCAPG)[15]. In addition,
some of the loci were novel and are now a clear focus of
attention in height biology.
In this study we aimed at examining these initial and
meta-analysis findings that were previously reported to
be genome wide significant in a large European American
pediatric cohort with height measurements to determine
the relative impact of these variants on childhood stature.
For this purpose, we leveraged genotyping data from our
ongoing GWA study of height variation in children.
Methods
Study population
All subjects were consecutively recruited from the
Greater Philadelphia area from 2006 to 2009 at the Chil-
dren's Hospital of Philadelphia and its Primary Care Cen-
ters. Our study cohort consisted of 8,184 children of
European ancestry with height information. All subjects
were biologically unrelated and were aged between 0 and
18 years old. The basic characteristics of the study sub-
jects are outlined in Table 1. This study was approved by
the Institutional Review Board of the Children's Hospital
of Philadelphia. Parental informed consent was given for
each study participant for both the blood collection and
subsequent genotyping.
Genotyping
We performed high throughput genome-wide SNP geno-
typing using either the Illumina Infinium™ II
HumanHap550 or Human 610 BeadChip technology in
the same manner as our center has reported previ-
ously[16]. The SNPs analyzed survived the filtering of the
genome wide dataset for SNPs with call rates < 95%,
minor allele frequency < 1%, missing rate per person < 2%
and Hardy-Weinberg equilibrium P < 10-5.
Loci described from GWA studies published to date
have been found using either the Affymetrix or Illumina
platform. In the event a locus was reported using both the
Illumina and Affymetrix arrays, we used the SNPs pres-
ent on the Illumina array. In the event of a signal only
being described on the Affymetrix array, we either
already had that SNP on our Illumina array or we identi-
fied and used the best surrogate SNP available (see Addi-
tional file 1: Supplemental Table S1 for the surrogates
employed).
Statistical analyses
From our database of heights for our multi-dimensional
scaling (MDS) determined Caucasians, as previously
described[17-19] and resulting in a low genomic inflation
factor, we eliminated height outliers using 2% cutoff for
each age category in order to remove potential measure-
ment error. As height values vary widely across pediatric
age groups and gender, we calculated the Z-scores using
inverse-normal transformation for each age (one year
bin) and gender category, and conducted association
analysis with the Z-scores as the outcome variable.
We queried the data for the indicated SNPs in our pedi-
atric samples. All statistical analyses were carried out
using the software package plink[20]. By treating the Z-
Table 1: Basic characteristics of the study subjects, 
including sample size and mean height plus standard 
deviation (S.D.) for each age and gender separately
MALE FEMALE
Age N Average 
Height 
(cm)
S.D. NA v e r a g e  
Height (cm)
S.D.
Under 2 673 73.51 10.33 424 73.04 8.86
2 319 88.92 5.79 200 87.87 6.40
3 318 97.72 5.50 244 96.17 5.58
4 279 104.22 5.97 183 103.66 6.30
5 215 110.75 7.05 175 110.40 6.88
6 218 119.01 7.23 177 117.98 6.52
7 219 125.14 7.42 159 124.19 7.23
8 197 130.01 7.81 157 128.87 7.56
9 196 135.56 8.20 145 133.52 9.99
10 184 139.98 8.73 177 139.64 8.62
11 188 145.59 9.39 188 147.47 9.06
12 220 150.60 10.64 181 152.92 9.17
13 221 157.79 10.28 243 157.21 8.40
14 237 164.66 9.40 248 160.25 7.25
15 252 169.09 9.48 260 161.39 7.69
16 201 172.90 7.90 275 162.64 6.77
17 171 174.38 8.52 216 162.89 7.29
18 113 174.60 7.01 111 163.47 7.58Zhao et al. BMC Medical Genetics 2010, 11:96
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score for height as a quantitative trait, association analy-
sis for each SNP was carried out using linear regression
with the SNP included as an independent variable (coded
as 0, 1, and 2, counting the number of minor alleles at the
SNP).
The results for Figure 1 were generated by summing the
number of height increasing alleles across all 16 height-
associated SNPs in our study to in order to produce a
scatter plot showing the impact of the genotype score on
the cumulative height Z-score.
Results
The 51 SNPs corresponding to the 46 previously reported
height loci were investigated with respect to their associ-
ation to normalized pediatric height in MDS-determined
European Americans (Table 2; also Additional file 2: Sup-
plemental Table S2 for analyses by age categories).
In summary, sixteen of these SNPs yielded at least
nominally significant association to height (P < 0.05), rep-
resenting fifteen different loci with the same direction of
effect as previously reported. Of these fifteen loci, varia-
tion at the EFEMP1-PNPT1 locus yielded the strongest
association with P = 1.39×10-5, namely rs3791679.
With a slightly lower magnitude of association was
GPR126  with rs3748069 yielding a P  = 3.64×10-4,
C6orf173  (also known as LOC387103) with rs1490388
yielding a P = 7.20×10-4, SPAG17 with 118574711 yielding
a P = 7.27×10-4 and the Histone class 1 gene cluster with
rs10946808 yielding a P = 9.57×10-4.
Overall, in addition to these loci, we found evidence for
association at the HLA class III region, UQCC-GDF5,
C6orf106,  JAZF1, ZBTB38, PLAG1, C1orf19-GLT25D2,
LCORL-NCAPG, CABLES1-RBBP8-C18orf45 and
SCMH1 loci. One could argue that we have carried out
multiple testing in our height cohort for these previously
reported SNPs, albeit at a number of magnitudes less
than for a full GWA study. If we were to apply the strictest
correction, i.e. the Bonferroni correction based on 51
SNPs, then EFEMP1-PNPT1, GPR126, C6orf173, SPAG17
and the Histone class 1 gene cluster would still be consid-
ered significant and their effects are consistent with the
outcomes of the adult GWA studies.
It was also observed that SNPs residing at the 31 other
loci did not reveal any evidence of association with height
in our pediatric cohort, most notably HMGA2.
Finally, we investigated the sixteen significant SNPs fur-
ther by testing for association between height Z-score
and the genotype score, by summing the number of
height increasing alleles across all these SNPs. The result-
ing P-value for the genotype score was < 2×10-16 (Figure
1). The genotype score explains 1.64% of the total varia-
tion for height z-score. We also tested pair-wise interac-
tions between the sixteen significant SNPs, but none of
the interaction effects were significant, suggesting that
these sixteen SNPs act additively on pediatric height.
Discussion
We queried the existing dataset from our ongoing GWAS
of pediatric height in European Americans for adult
height loci uncovered in GWAS to date. We examined 51
single nucleotide polymorphisms (SNPs) corresponding
to 46 genomic loci in 8,184 children with height measure-
ments. Sixteen of these SNPs yielded at least nominally
significant association to the trait, representing fifteen
different loci.
One of the more notable results is the negative associa-
tion with HMGA2. This gene is one of the most strongly
associated loci with adult height[9] so its lack of associa-
tion with childhood stature in this study is striking. We
previously published a replication attempt with this locus
and pediatric height when our cohort was substantially
smaller[21]; at that time, we observed nominal associa-
tion but it is clear that as our cohort has grown, this sig-
nal has failed to strengthen. Despite the wealth the
evidence from adult GWA studies and from previous
work with knock-out mouse models, it is of surprise not
to observe association with HMGA2. However, when
considering the age bins presented in Additional file 2:
Supplemental Table S2, the T statistic generally increases
with age, with the strongest value being for the 15-18 age
group. Although none of these observations are signifi-
cant, it may point to an age-specific effect at a particular
point during childhood that is undetected in the overall
analysis; however our large cohort size may still not be
powered enough to tease out this effect.
Figure 1 Scatter plot for association between height z-score and 
the genotype score by summing the number of height increasing 
alleles across all 16 height-associated SNPs.Z
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Table 2: Quantitative association results for the candidate loci in the European American height cohort (n = 8,184), sorted by chromosomal location. 
Chr Minor Allele SNP Position (Build 36) Nearby genes(s) NMISS MAF BETA SE R2 T P
1 A rs11809207 26205282 CATSPER4 8106 0.1730 0.02775 0.0213 0.0002095 1.303 0.1926
1 C rs6663565 41232781 SCMH1 8184 0.4297 0.03744 0.01587 0.0006802 2.36 0.0183
1 C rs17038164 118574711 SPAG17 8182 0.2601 -0.06029 0.01784 0.001395 -3.38 0.0007274
1 G rs11205277 146705945 Histone class 2A, MTMR11, SV2A, SF3B4 8182 0.4195 0.0109 0.01579 5.83E-05 0.6906 0.4898
1 G rs678962 168921546 DNM3 8178 0.2183 0.01272 0.0192 5.37E-05 0.6625 0.5077
1 A rs2274432 180752602 C1orf19, GLT25D2 7965 0.3237 0.04568 0.01722 0.0008828 2.653 0.008003
1 A rs3942992 224079131 ZNF678 8181 0.1725 9.96E-05 0.02072 2.83E-09 0.004809 0.9962
2 G rs3791679 56008543 EFEMP1, PNPT1 8179 0.2539 -0.0782 0.01798 0.002308 -4.349 1.39×10-5
2 T rs1052483 219759853 IHH, CRYBA2, FEV, SLC23A3, TUBA1 8110 0.0956 -0.04701 0.02686 0.0003777 -1.75 0.08009
3 C rs9841212 135674636 ANAPC13, CEP63 8154 0.3289 -0.006868 0.01676 2.06E-05 -0.4098 0.682
3 A rs6763931 142585531 ZBTB38 8174 0.4091 0.04634 0.01587 0.001042 2.92 0.003513
4 T rs6842303 17530324 LCORL, NCAPG 8173 0.2466 0.02231 0.01823 0.0001834 1.224 0.2209
4 C rs6830062 17693999 LCORL, NCAPG 8184 0.1883 -0.05215 0.02014 0.0008192 -2.59 0.009613
4 A rs1812175 145932449 HHIP 8172 0.1639 -0.03329 0.02125 0.0003002 -1.566 0.1173
5 T rs10472828 32924575 NPR3 8182 0.4585 -0.005366 0.01589 1.39E-05 -0.3376 0.7357
6 A rs12198986 7665058 BMP6 8183 0.4516 -
0.0003072
0.01598 4.52E-08 -0.01922 0.9847
6 G rs10946808 26341366 Histone class 1, Butyrophilin genes 8164 0.2923 -0.05734 0.01736 0.001336 -3.304 0.0009572
6 C rs2844479 31680935 HLA class III 8183 0.3890 -0.03031 0.01605 0.0004355 -1.888 0.05907
6 G rs3130050 31726740 HLA class III 8178 0.1249 0.06717 0.02369 0.0009819 2.835 0.004598
6 T rs185819 32158045 HLA class III 8178 0.4576 0.0516 0.01576 0.001309 3.274 0.001066
6 G rs1776897 34302989 HMGA1, LBH 8183 0.0940 0.02524 0.02701 0.0001068 0.9348 0.3499
6 A rs2814993 34726871 C6orf106 8091 0.1390 0.06941 0.02284 0.001141 3.039 0.002378
6 A rs4713858 35510763 ANKS1, TCP11, ZNF76, DEF6, SCUBE3 8184 0.1730 -0.02058 0.02103 0.000117 -0.9786 0.3278
6 C rs314263 105499438 LIN28B, HACE1, BVES, POPDC3 8184 0.3129 0.02821 0.01698 0.0003373 1.661 0.09665
6 T rs1490388 126877348 C6orf173/LOC387103 8179 0.4784 0.05315 0.01571 0.001398 3.383 0.0007196
6 G rs3748069 142809326 GPR126 8184 0.3126 -0.06047 0.01695 0.001552 -3.566 0.0003641
7 T rs798544 2536343 GNA12 8184 0.2897 0.009501 0.01746 3.62E-05 0.5441 0.5864
7 C rs1182188 2643226 GNA12 8184 0.2948 0.01528 0.01742 9.40E-05 0.8769 0.3806
7 A rs849141 27958331 JAZF1 8180 0.2729 0.05199 0.01769 0.001055 2.939 0.0033Z
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7 C rs2282978 91909061 CDK6, PEX1, GATAD1, ERVWE1 8180 0.3562 -
0.0002285
0.01639 2.38E-08 -0.01394 0.9889
7 C rs11765954 91925346 CDK6, PEX1, GATAD1, ERVWE1 8183 0.2866 0.006002 0.01744 1.45E-05 0.3441 0.7307
8 C rs10958476 57258362 PLAG1, MOS, CHCHD7, RDHE2, RPS20, LYN, 
TGS1, PENK
8158 0.2015 0.05689 0.01979 0.001012 2.874 0.004062
8 C rs7846385 78322734 PXMP3, ZFHX4 8175 0.2753 0.004128 0.01761 6.72E-06 0.2344 0.8147
9 G rs4448343 95345925 PTCH1 8182 0.3217 -0.007508 0.01686 2.42E-05 -0.4453 0.6561
9 A rs4743034 106711908 ZNF462 8183 0.2250 0.01859 0.01872 0.0001206 0.9933 0.3206
12 C rs8756 64646019 HMGA2 8175 0.4607 0.02308 0.01586 0.0002588 1.455 0.1458
12 G rs3825199 92479422 SOCS2, MRPL42, CRADD, UBE2N 8183 0.2088 0.02109 0.0194 0.0001445 1.087 0.2769
13 C rs1239947 50004556 DLEU7 8183 0.3287 0.03243 0.01678 0.0004563 1.933 0.05333
14 C rs910316 74695795 TMED10 8184 0.4863 -0.02021 0.01577 0.0002006 -1.281 0.2002
14 C rs7153027 91496975 TRIP11, FBLN5, ATXN3, CPSF2 8149 0.4316 -0.02966 0.0158 0.0004323 -1.877 0.06054
15 C rs2554380 82106888 ADAMTSL3, SH3GL3 8067 0.1991 0.01455 0.02029 6.38E-05 0.7171 0.4734
15 T rs11633371 87157836 ACAN 8184 0.4636 0.02862 0.01575 0.0004032 1.817 0.06929
15 A rs4533267 98603794 ADAMTS17 8184 0.2933 -0.001093 0.01737 4.84E-07 -0.06294 0.9498
17 A rs3760318 26271841 CRLF3, ATAD5, CENTA2, RNF135 8184 0.3821 -0.03009 0.01627 0.0004178 -1.849 0.06444
17 A rs4794665 52205328 NOG, DGKE, TRIM25, COIL, RISK 8183 0.4756 0.006489 0.01569 2.09E-05 0.4135 0.6792
17 A rs757608 56852059 BCAS3, NACA2, TBX2, TBX4 8126 0.3322 0.02008 0.01676 0.0001767 1.198 0.2309
18 G rs4800148 18978326 CABLES1, RBBP8, C18orf45 8183 0.2043 -0.04987 0.01943 0.0008048 -2.567 0.01028
18 T rs530550 45105636 DYM 8182 0.3572 -0.01124 0.01631 5.81E-05 -0.6892 0.4907
19 G rs12459350 2127586 DOT1L 8179 0.4744 0.02751 0.01579 0.0003711 1.742 0.08149
20 A rs967417 6568893 BMP2 8184 0.4495 -0.02479 0.01591 0.0002964 -1.558 0.1194
20 C rs4911494 33435328 UQCC, GDF5, CEP250, EIF6, MMP24 8182 0.3864 0.05107 0.01621 0.001212 3.151 0.001633
The SNPs in bold are those that survived correction for multiple testing.
NMISS: number of individuals tested; MAF: minor allele frequency; BETA: regression coefficient for the test SNP; SE: standard error of the regression coefficient; R2: r2 value in linear regression; T: 
test statistic; P: two-sided trend test P-value. The direction of effect is shown for the minor allele in each case.
Table 2: Quantitative association results for the candidate loci in the European American height cohort (n = 8,184), sorted by chromosomal location.  (Continued)Zhao et al. BMC Medical Genetics 2010, 11:96
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For the loci we did not observe any evidence for associ-
ation at all may be due to power issues, but could also
indicate that they have a less pronounced role in a pediat-
ric setting. In addition, only a portion of the published
adult height loci have been independently and robustly
replicated to date[22]. It should also be noted that child-
hood growth is an ongoing process where development
factors may cloud detection at certain loci, including at
the two rapid growth stages, where nutrition plays a
major role in infant growth and hormone signaling
impacts at puberty. Our study may lack power to detect
stage specific association when using a mixed age child-
hood cohort; however we have presented the association
results for specific age bins in Additional file 2: Supple-
mental Table S2.
From this analysis, it is clear that a number of loci pre-
viously reported from GWA analyses of adult height also
play a role in our phenotype of interest. While these
recently discovered loci unveil several new biomolecular
pathways not previously associated with height, it is
important to note that these well established genetic
associations with stature explain very little of the genetic
contribution for this pediatric phenotype, suggesting the
existence of additional loci whose number and effect size
remain unknown.
Conclusions
Among 46 loci that have been reported to associate with
adult height to date, at least 15 also contribute to the
determination of height in childhood. Once our GWA
study is complete, we will have the opportunity to look
for other variants in the genome that are associated with
height in childhood.
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